Pityriasis rosea like eruption secondary to topiramate: case report
نویسندگان
چکیده
منابع مشابه
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug erupti...
متن کاملIchthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review
Tyrosine kinase inhibitors have revolutionized the chemotherapy arena as targeted therapies for a multitude of malignancies. They are more selective than conventional chemotherapy, and often elicit fewer systemic adverse events, however toxicities still exist. Cutaneous toxicities are common and their management presents a novel challenge to physicians and patients. Ponatinib is a third-generat...
متن کاملAtypical Pityriasis rosea in a black child: a case report
INTRODUCTION Pityriasis rosea is a self-limited inflammatory condition of the skin that mostly affects healthy children and adolescents. Atypical cases of Pityriasis rosea are fairly common and less readily recognized than typical eruptions, and may pose a diagnostic challenge. CASE PRESENTATION We report the case of a 12-year-old black child that developed an intense pruritic papular eruptio...
متن کاملIbrutinib-associated pityriasis rosea–like rash
CLL: chronic lymphocytic leukemia PR: pityriasis rosea EGFR: epidermal growth factor receptor PDGFR: platelet-derived growth factor receptor I brutinib, a Bruton tyrosine kinase inhibitor, is a new oral agent approved for the treatment of chronic lymphocytic leukemia (CLL). Ibrutinib is well-tolerated, with the majority of its adverse events within grade 1 or 2 severity. The most common nonhema...
متن کاملPityriasis rosea.
T HE Medical Research Council's investigation into pityriasis rosea in 1959 has already been published (Proc. roy. Soc. Med., 55, 556). This second investigation, based on a very simple questionnaire, has produced some additional information, but has not altogether solved the question put, namely "What is the cause of this disease?" Much interest was shown. In 1964, 180 observers notified 531 c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Dermatology & Cosmetology
سال: 2018
ISSN: 2574-9943
DOI: 10.15406/jdc.2018.02.00070